This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Fawn Coles - Innovator in Pharmaceutical Research
Introduction
Fawn Coles is a notable inventor based in Cardiff, California. She has made significant contributions to the field of pharmaceutical research, particularly in the development of peptide substrates for metalloproteases.
Latest Patents
Fawn Coles holds a patent for "Aggrecanase-1 and -2 peptide substrates and methods." This invention describes synthetic peptide substrates of the metalloproteases, aggrecanase-1 and/or -2, which are suitable for assays of enzyme activity. The invention also outlines methods using these peptides to discover pharmaceutical agents that modulate these proteases. She has 1 patent to her name.
Career Highlights
Fawn Coles is associated with Ortho-McNeil Pharmaceutical Corporation, where she applies her expertise in pharmaceutical innovation. Her work focuses on advancing the understanding and treatment of diseases through innovative peptide substrates.
Collaborations
Fawn has collaborated with notable colleagues, including Lars Karlsson and Anne Fourie, who contribute to her research endeavors.
Conclusion
Fawn Coles exemplifies the spirit of innovation in the pharmaceutical industry through her groundbreaking work on peptide substrates. Her contributions are paving the way for new therapeutic agents that can significantly impact healthcare.